Quan Dong Nguyen

This early-stage study is testing a new cell therapy called TRX103 for adults with active non-infectious uveitis, a serious inflammatory eye disease. Researchers will give a single infusion to up to 18 participants and monitor them for one year to check safety and see if it helps…